Exchange: OTC·Updated 03:59 PM EDT
News
all
press releases
CYDY Stock Falls Despite Positive Cancer Study Data – Retail Says CytoDyn Is ‘Here To Stay’
CytoDyn presented new data from a Phase 2 study for metastatic colorectal cancer at the AACR Annual Meeting in San Diego.
Stocktwits

Advertisement|Remove ads.